Research use only. Sermorelin is sold strictly as a reference material for in-vitro and laboratory research. Nothing here is medical advice, a dosing protocol, or a statement of human efficacy — it summarises how the published literature characterises the peptide. Every batch we list is published with its independent Janoshik HPLC certificate.
What sermorelin is
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth-hormone-releasing hormone (GHRH) — written GHRH(1–29). Those 29 residues are the shortest fragment that retains full GHRH biological activity, which is why sermorelin is treated in the literature as the minimal functional GHRH analog. It acts on the GHRH receptor on pituitary somatotrophs, prompting growth-hormone release through the same pathway as native GHRH.
The defining feature: a short, physiologic pulse
Sermorelin has a short half-life — on the order of minutes in research models. In the literature this is framed as a feature rather than a limitation: it produces a brief, pulsatile GH release that mirrors the body’s own episodic GHRH signalling, leaving the downstream feedback loops (somatostatin, IGF-1) intact. That makes it the reference compound when a study wants GHRH-receptor stimulation that follows physiological rhythm rather than a sustained signal.
Sermorelin vs CJC-1295 vs tesamorelin
All three are GHRH-receptor analogs, distinguished mainly by half-life:
- Sermorelin — GHRH(1–29); shortest-acting; physiologic pulse.
- CJC-1295 — a modified GHRH analog with substitutions (and, in the DAC form, albumin binding) that extend its half-life substantially. The DAC vs no-DAC distinction is covered in our CJC-1295 guide.
- Tesamorelin — a stabilised GHRH analog studied in its own metabolic context.
Sermorelin also appears constantly in the GHRH-plus-GHRP literature — paired with a ghrelin-receptor agonist such as ipamorelin to study complementary pathways. That broader picture is in our growth hormone secretagogues guide.
What the research investigates
- GH/IGF-1 axis. The core theme — GHRH-receptor stimulation and downstream GH and IGF-1 dynamics in research models.
- Age-related GH decline models. Sermorelin is a long-standing reference in studies of the somatotropic axis across age.
- Pulsatility research. Its short action makes it the tool of choice for studying episodic versus sustained GHRH signalling.
What the literature does NOT establish
No validated human dosing protocol, no established human efficacy claim, and no long-term human safety data are asserted here. Sermorelin’s research record is substantial but remains a research record. Treat it strictly as a laboratory reference compound.
Handling and reconstitution
Sermorelin ships as lyophilised powder and must be reconstituted before laboratory work; reconstitution volume sets concentration per unit, so calculate it with our reconstitution guide rather than estimating.
Verifying what you receive
The sermorelin we list is published with the independent Janoshik HPLC certificate that accompanies its batch — see the lab results archive; the task ID resolves on Janoshik’s own domain.
Frequently asked questions
What is sermorelin?
A synthetic peptide equal to the first 29 amino acids of GHRH — the minimal fragment that keeps full GHRH activity. It is a GHRH-receptor agonist.
How is sermorelin different from CJC-1295?
Both are GHRH analogs, but sermorelin is short-acting (physiologic pulse) while CJC-1295 is modified for a much longer half-life, especially the DAC form.
Why is its short half-life considered useful?
It produces brief, pulsatile GH release that mirrors the body’s own GHRH rhythm, leaving feedback loops intact — useful when studying physiologic rather than sustained signalling.
Is sermorelin used with other peptides in research?
Yes — it is frequently paired with a GHRP such as ipamorelin to study complementary GHRH + ghrelin-receptor pathways. See the GH secretagogues guide.
How do I verify the purity of the batch I receive?
Each batch we list is published with its independent Janoshik HPLC certificate and a public verify link on Janoshik’s own domain.
Is sermorelin for human use?
No. It is sold strictly as a research-use-only reference material and is not intended for human or veterinary use.
Summary
Sermorelin is the minimal, short-acting GHRH analog — GHRH(1–29) — used as the physiologic-pulse reference in growth-hormone-axis research, and as the GHRH half of the classic GHRH + GHRP pairing. Match it to the question, reconstitute it correctly, and confirm the batch against its published Janoshik certificate.